HDAC4 and Familial prostate cancer: It is exciting that four compounds – used in other diseases such as prostate cancer – targeted HDAC4 activity, reversed the impaired expression of the HDAC4-controlled genes and subsequently ameliorated pertubations in autophagy and lysosomal pathways.